摘要
目的:本研究旨在研究芹菜素(API)对人舌鳞状细胞癌Tca8113细胞增殖、迁移和侵袭的影响,并探讨其可能的机制。 方法:用API处理Tca8113细胞后,采用四唑盐比色法(MTT)、细胞划痕试验和Transwell小室试验检测细胞增殖、迁移和侵袭能力。细胞免疫荧光染色用于定位丝裂原活化蛋白激酶 1 (MAPK1) 和细胞外调节蛋白激酶 (ERK) 1/2 蛋白。 Western blot检测相关蛋白表达水平的变化。 结果:①MTT法测定,API显着抑制细胞增殖(P<0.01)。 ②细胞划痕试验中,API处理后的横向迁移距离较对照组明显缩短(P<0.01)。 ③API组Transwell小室下室浸润率较低(P<0.01)。 ④细胞免疫荧光染色显示总MEKK1定位于细胞质,p-MEKK1定位于核膜和细胞质,p-ERK1/2定位于细胞质和细胞核。 ⑤ API 应用于细胞后,p-MEKK1 和p-ERK1/2 蛋白的表达显着降低(P<0.01)。 结论:芹菜素(API)显着抑制Tca8113细胞的增殖、迁移和侵袭,其机制可能与MAPK信号通路有关。
关键词: 芹菜素 (API)、Tca8113 细胞、丝裂原活化蛋白激酶信号通路、细胞增殖、MTT、ERK。
Current Molecular Medicine
Title:Apigenin Inhibits Proliferation, Migration, and Invasion of Human Tongue Carcinoma Tca8113 Cells Through Regulating the MAPK Signaling Pathways
Volume: 21 Issue: 8
关键词: 芹菜素 (API)、Tca8113 细胞、丝裂原活化蛋白激酶信号通路、细胞增殖、MTT、ERK。
摘要:
Objective: This study aimed to examine the effects of apigenin (API) on the proliferation, migration, and invasion of human tongue squamous cell carcinoma Tca8113 cells and explore its probable mechanisms.
Methods: After treating Tca8113 cells with API, the cell proliferation, migration, and invasive capacities were identified by tetrazolium salt colorimetry (MTT) assay, cell scratch test, and Transwell chamber test. Cellular immunofluorescence staining was used to localize mitogen-activated protein kinase 1 (MAPK1) and extracellular regulated protein kinase (ERK) 1/2 proteins. Western blot was used to detect the variations of the related protein expression levels.
Results:① Through the MTT assay, API significantly inhibited cell proliferation (P<0.01). ②In the cell scratch test, the distance of lateral migration after the API treatment was significantly shorter compared to the control group (P<0.01). ③The invasion rate in the lower chamber of the Transwell chamber was lower in the API group (P<0.01). ④ Cellular immunofluorescence staining presented that the total-MEKK1 was localized in the cytoplasm, p-MEKK1 was localized in the nuclear membrane and cytoplasm, and p-ERK1/2 was localized in the cytoplasm and nucleus. ⑤ After API was applied to cells, the expressions of p-MEKK1 and p-ERK1/2 proteins significantly reduced (P<0.01).
Conclusion: Apigenin (API) significantly inhibits the proliferation, migration, and invasion of Tca8113 cells and its mechanism may be associated with the MAPK signaling pathway.
Export Options
About this article
Cite this article as:
Apigenin Inhibits Proliferation, Migration, and Invasion of Human Tongue Carcinoma Tca8113 Cells Through Regulating the MAPK Signaling Pathways, Current Molecular Medicine 2021; 21 (8) . https://dx.doi.org/10.2174/1566524020666201022120420
DOI https://dx.doi.org/10.2174/1566524020666201022120420 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Monoclonal Antibodies in Clinical Practice against Cancer
Anti-Cancer Agents in Medicinal Chemistry Current View on the Mechanism of Action of Perifosine in Cancer
Anti-Cancer Agents in Medicinal Chemistry IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Paclitaxel Efficacy is Increased by Parthenolide via Nuclear Factor- KappaB Pathways in In Vitro and In Vivo Human Non–Small Cell Lung Cancer Models
Current Cancer Drug Targets Stereotactic Body Radiotherapy in the Management of Head and Neck Malignancies
Current Cancer Therapy Reviews Elucidation of PLK1 Linked Biomarkers in Oesophageal Cancer Cell Lines: A Step Towards Novel Signaling Pathways by p53 and PLK1-Linked Functions Crosstalk
Protein & Peptide Letters Nitric Oxide is a Key Molecule Serving as a Bridge between Radiation-Induced Bystander and Adaptive Responses
Current Molecular Pharmacology Epigenetic Biomarkers for Risk Assessment of Particulate Matter Associated Lung Cancer
Current Drug Targets Inhibitors of the HSP90 Molecular Chaperone: Attacking the Master Regulator in Cancer
Current Topics in Medicinal Chemistry Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
Current Molecular Medicine Monoclonal Antibodies in Solid Tumours
Current Clinical Pharmacology Rho GTPase Activating Proteins in Cancer Phenotypes
Current Protein & Peptide Science Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis
Current Cancer Therapy Reviews The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases
Current Pharmaceutical Design Radiolabeled Compounds in the Development of Cytotoxic Agents
Current Pharmaceutical Design Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention
Current Pharmaceutical Design Minichromosome Maintenance Complex is Required for Checkpoint Kinase 2 Chromatin Loading and its Phosphorylation to DNA Damage Response in SCC-4 Cells
Protein & Peptide Letters Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Recent Advances in Management of Diabetic Macular Edema
Current Diabetes Reviews Estrogen-Induced Genetic Alterations and Their Role in Carcinogenicity
Current Genomics